Eversept Partners, LP
Top Portfolio Positions
110 positions ·
$1,817,420,308 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
264,271 | $156,707,417 | 8.62% |
| QQQ |
Invesco Qqq Trust, Series 1
|
238,700 | $137,772,866 | 7.58% |
| ABVX |
Abivax S.A.
Healthcare
|
934,423 | $104,048,001 | 5.73% |
| GSK |
GSK plc
Healthcare
|
1,785,175 | $98,523,808 | 5.42% |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
2,173,286 | $87,431,295 | 4.81% |
| NTRA |
Natera, Inc.
Healthcare
|
384,713 | $76,938,752 | 4.23% |
| SPY |
Spdr S&P 500 Etf Trust
|
107,000 | $69,586,380 | 3.83% |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
2,885,622 | $67,408,129 | 3.71% |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
1,788,016 | $56,715,867 | 3.12% |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
924,193 | $53,704,855 | 2.96% |
Holdings in CTMX
Export CSV
1 of 1 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,986,015 | 3,188,514 | Shares | Sole | 2026-05-15 | |
| No quarters match your search. | ||||||